Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Conflict of Interest | 2 | 2021 | 544 | 1.050 |
Why?
|
| Thrombosis | 4 | 2023 | 2968 | 0.810 |
Why?
|
| Pipecolic Acids | 1 | 2021 | 76 | 0.760 |
Why?
|
| Extracorporeal Circulation | 1 | 2021 | 182 | 0.750 |
Why?
|
| Gift Giving | 1 | 2021 | 80 | 0.750 |
Why?
|
| Aneurysm | 1 | 2023 | 339 | 0.740 |
Why?
|
| Aortic Aneurysm | 2 | 2022 | 643 | 0.700 |
Why?
|
| Compensation and Redress | 1 | 2020 | 71 | 0.700 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2024 | 1390 | 0.690 |
Why?
|
| Cell-Derived Microparticles | 1 | 2021 | 168 | 0.690 |
Why?
|
| Peripheral Arterial Disease | 4 | 2023 | 1188 | 0.650 |
Why?
|
| Antithrombins | 1 | 2021 | 304 | 0.630 |
Why?
|
| Diabetic Foot | 1 | 2022 | 355 | 0.630 |
Why?
|
| Health Care Sector | 1 | 2020 | 194 | 0.620 |
Why?
|
| Arginine | 1 | 2021 | 944 | 0.600 |
Why?
|
| Aortic Diseases | 1 | 2023 | 742 | 0.590 |
Why?
|
| Authorship | 1 | 2020 | 271 | 0.570 |
Why?
|
| Fibromyalgia | 1 | 2020 | 388 | 0.540 |
Why?
|
| Informed Consent | 1 | 2022 | 995 | 0.530 |
Why?
|
| Truth Disclosure | 1 | 2020 | 436 | 0.530 |
Why?
|
| Vascular Surgical Procedures | 2 | 2021 | 1475 | 0.520 |
Why?
|
| Disclosure | 1 | 2021 | 736 | 0.510 |
Why?
|
| Editorial Policies | 1 | 2020 | 451 | 0.510 |
Why?
|
| Nitric Oxide | 1 | 2021 | 2132 | 0.420 |
Why?
|
| Sulfonamides | 1 | 2021 | 1938 | 0.400 |
Why?
|
| Blood Platelets | 2 | 2022 | 2508 | 0.390 |
Why?
|
| Students, Medical | 1 | 2022 | 1862 | 0.350 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 2576 | 0.330 |
Why?
|
| Self Report | 1 | 2020 | 3558 | 0.330 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 1432 | 0.330 |
Why?
|
| Venous Thromboembolism | 3 | 2023 | 1671 | 0.270 |
Why?
|
| Vascular Patency | 2 | 2023 | 886 | 0.240 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5751 | 0.230 |
Why?
|
| Thrombelastography | 2 | 2022 | 164 | 0.230 |
Why?
|
| Pandemics | 2 | 2022 | 8388 | 0.230 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2022 | 65 | 0.210 |
Why?
|
| Urinary Retention | 1 | 2023 | 111 | 0.210 |
Why?
|
| Consent Forms | 1 | 2022 | 53 | 0.210 |
Why?
|
| Ulcer | 1 | 2023 | 209 | 0.210 |
Why?
|
| Popliteal Artery | 1 | 2023 | 317 | 0.200 |
Why?
|
| Shoes | 1 | 2022 | 97 | 0.200 |
Why?
|
| Puerperal Disorders | 1 | 2022 | 275 | 0.180 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2023 | 549 | 0.170 |
Why?
|
| Endovascular Procedures | 2 | 2024 | 1979 | 0.170 |
Why?
|
| Aorta | 2 | 2023 | 2061 | 0.160 |
Why?
|
| Hematoma | 1 | 2023 | 758 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 4 | 2023 | 3068 | 0.160 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2022 | 500 | 0.160 |
Why?
|
| Endarterectomy, Carotid | 1 | 2023 | 546 | 0.160 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2017 | 44 | 0.160 |
Why?
|
| Treatment Outcome | 9 | 2024 | 63114 | 0.150 |
Why?
|
| Bibliometrics | 1 | 2021 | 339 | 0.150 |
Why?
|
| Platelet Activation | 1 | 2021 | 673 | 0.150 |
Why?
|
| Hypotension | 1 | 2023 | 884 | 0.150 |
Why?
|
| Pain Threshold | 1 | 2020 | 584 | 0.140 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2022 | 1261 | 0.130 |
Why?
|
| Carotid Stenosis | 1 | 2023 | 854 | 0.130 |
Why?
|
| Blood Coagulation | 1 | 2021 | 1127 | 0.130 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2022 | 686 | 0.130 |
Why?
|
| Humans | 27 | 2024 | 744343 | 0.130 |
Why?
|
| Monitoring, Intraoperative | 1 | 2021 | 957 | 0.130 |
Why?
|
| Rabbits | 1 | 2021 | 4894 | 0.120 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2024 | 1186 | 0.120 |
Why?
|
| Polymers | 1 | 2021 | 1621 | 0.120 |
Why?
|
| Ultrasonography | 2 | 2023 | 5985 | 0.120 |
Why?
|
| Publishing | 1 | 2021 | 833 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2021 | 1161 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2024 | 77449 | 0.110 |
Why?
|
| Motivation | 1 | 2022 | 1971 | 0.110 |
Why?
|
| Reperfusion Injury | 1 | 2019 | 1026 | 0.110 |
Why?
|
| Internship and Residency | 2 | 2022 | 5788 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 1519 | 0.100 |
Why?
|
| General Surgery | 1 | 2022 | 1636 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 2170 | 0.090 |
Why?
|
| Emotions | 1 | 2020 | 2661 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3255 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 2624 | 0.080 |
Why?
|
| United States | 4 | 2023 | 69872 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 12261 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 7913 | 0.070 |
Why?
|
| Insulin | 1 | 2020 | 6580 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 9274 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2017 | 1972 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4468 | 0.060 |
Why?
|
| Anticoagulants | 3 | 2023 | 4599 | 0.060 |
Why?
|
| Sepsis | 1 | 2017 | 2593 | 0.060 |
Why?
|
| Endoleak | 1 | 2024 | 106 | 0.060 |
Why?
|
| Hypertension | 1 | 2023 | 8480 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2022 | 6487 | 0.050 |
Why?
|
| Factor Xa | 1 | 2023 | 162 | 0.050 |
Why?
|
| Aortography | 1 | 2024 | 437 | 0.050 |
Why?
|
| Kidney | 1 | 2017 | 7186 | 0.050 |
Why?
|
| Anesthesia, Local | 1 | 2024 | 275 | 0.050 |
Why?
|
| Ultrasonography, Doppler | 1 | 2023 | 458 | 0.050 |
Why?
|
| Thrombin | 1 | 2023 | 598 | 0.050 |
Why?
|
| Water Deprivation | 1 | 2019 | 21 | 0.040 |
Why?
|
| Platelet Aggregation | 1 | 2022 | 798 | 0.040 |
Why?
|
| Food Deprivation | 1 | 2019 | 116 | 0.040 |
Why?
|
| Glycosylation | 1 | 2022 | 1126 | 0.040 |
Why?
|
| Female | 6 | 2023 | 380194 | 0.040 |
Why?
|
| Heart Failure | 1 | 2022 | 10900 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2023 | 952 | 0.040 |
Why?
|
| Faculty | 1 | 2022 | 386 | 0.040 |
Why?
|
| Cultural Diversity | 1 | 2022 | 359 | 0.040 |
Why?
|
| Tyrosine | 1 | 2022 | 1461 | 0.040 |
Why?
|
| Postoperative Hemorrhage | 1 | 2021 | 413 | 0.040 |
Why?
|
| Fluorometry | 1 | 2017 | 106 | 0.040 |
Why?
|
| Fluoresceins | 1 | 2017 | 235 | 0.040 |
Why?
|
| Ticlopidine | 1 | 2023 | 899 | 0.040 |
Why?
|
| Blood Loss, Surgical | 1 | 2021 | 662 | 0.040 |
Why?
|
| Angiography | 1 | 2023 | 1639 | 0.040 |
Why?
|
| Cell Line | 2 | 2022 | 15997 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2022 | 1086 | 0.030 |
Why?
|
| Workflow | 1 | 2020 | 847 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2020 | 2274 | 0.030 |
Why?
|
| Oligosaccharides | 1 | 2017 | 414 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2017 | 1420 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2021 | 1301 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2017 | 479 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2022 | 1158 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2023 | 53288 | 0.030 |
Why?
|
| Minority Groups | 1 | 2022 | 1223 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 21683 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2959 | 0.030 |
Why?
|
| Animals | 3 | 2021 | 168757 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 2046 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2023 | 2158 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2022 | 1181 | 0.030 |
Why?
|
| Risk Factors | 3 | 2024 | 72290 | 0.030 |
Why?
|
| Child | 1 | 2020 | 77709 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2023 | 2265 | 0.020 |
Why?
|
| Aspirin | 1 | 2023 | 3282 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2023 | 9849 | 0.020 |
Why?
|
| Length of Stay | 1 | 2023 | 6309 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 1917 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 2291 | 0.020 |
Why?
|
| Heart | 1 | 2022 | 4467 | 0.020 |
Why?
|
| Adult | 1 | 2022 | 214055 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 2872 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 8301 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2023 | 3749 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2023 | 7729 | 0.020 |
Why?
|
| Critical Illness | 1 | 2020 | 2670 | 0.020 |
Why?
|
| Male | 5 | 2023 | 350118 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2017 | 4199 | 0.020 |
Why?
|
| Hospitals | 1 | 2020 | 3952 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 9438 | 0.020 |
Why?
|
| Prevalence | 1 | 2023 | 15226 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2020 | 6256 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15076 | 0.020 |
Why?
|
| Phenotype | 1 | 2022 | 16365 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2022 | 15519 | 0.010 |
Why?
|
| Rats | 1 | 2019 | 24260 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14557 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 17446 | 0.010 |
Why?
|
| Pregnancy | 1 | 2022 | 29144 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 21827 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18029 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 40075 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 23403 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 163280 | 0.010 |
Why?
|
Concepts
(161)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_